Marketing-authorisation holder
Alcon Labs Inc
14 medicines in 1 country, as authorisation holder.
Loading…
Marketing-authorisation holder
14 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
14 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ALCAINE0.5% · Solution/drops | Proxymetacaine | United States | Marketed | 1971 |
| CYCLOGYL0.5% | 1% | 2% · Solution/drops | Cyclopentolate | United States | Marketed | 1974 |
| CYCLOMYDRIL0.2%; 1% · Solution/drops | Cyclopentolate, Phenylephrine | United States | Marketed | 1975 |
| EYSUVIS0.25% · Suspension/drops | Loteprednol | United States | Marketed | 2020 |
| FLUORESCITE500mg base/5ml (eq 100mg base/ml) · Injectable | Fluorescein | United States | Marketed | 2006 |
| INVELTYS1% · Suspension/drops | Loteprednol | United States | Marketed | 2018 |
| ISOPTO ATROPINE1% · Solution/drops | Atropine | United States | Marketed | 2016 |
| PATADAY ONCE DAILY RELIEF0.2% base | 0.7% base · Solution/drops | Olopatadine | United States | Marketed | 2004 |
| PATADAY TWICE DAILY RELIEF0.1% base · Solution/drops | Olopatadine | United States | Marketed | 1996 |
| RHOPRESSA0.02% base · Solution/drops | Netarsudil | United States | Marketed | 2017 |
| ROCKLATAN0.005%; 0.02% base · Solution/drops | Latanoprost, Netarsudil dimesylate | United States | Marketed | 2019 |
| SIMBRINZA0.2%; 1% · Suspension/drops | Brimonidine, Brinzolamide | United States | Marketed | 2013 |
| TETRACAINE HYDROCHLORIDE0.5% · Solution | Tetracaine | United States | Marketed | 2016 |
| TRYPTYR0.003% · Solution/drops | Acoltremon | United States | Marketed | 2025 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 14 | 14 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Keep Alcon Labs Inc’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callOther companies in the same group.